Davis George Eric's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed Feb 26, 2026
- Accession no.
- 0001628280-26-012533
- Filed
- Feb 26, 2026
- Trade date
- Feb 25-26, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.60M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis George EricCIK 0001380710 | Officer (EVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Common Stock | AGrant or awardAcquired | +6,177 | $0.00 | $0 | 89,467 | Direct | |
| Feb 25, 2026 | Common Stock | AGrant or awardAcquired | +6,675 | $0.00 | $0 | 96,142 | Direct | |
| Feb 25, 2026 | Common Stock | AGrant or awardAcquired | +2,372 | $0.00 | $0 | 98,514 | Direct | |
| Feb 26, 2026 | Common Stock | SSaleDisposed | −26,061 | $61.36 | −$1,599,102.96 | 72,453 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.